Test Price
4,600 AED✅ Home Collection Available
Chronic Myeloid Leukemia (CML) NGS Panel in UAE | 4600 AED | 2026 DHA Guidelines
تحليل لوحة سرطان الدم النخاعي المزمن (CML) بتقنية التسلسل الجيني المتقدم في الإمارات | 4600 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يضمن هذا الفحص دقة تشخيصية عالية تصل إلى 99.9% وفقًا لمعايير ISO، مع خدمة سحب عينات منزلية محترفة وسلسلة تبريد معتمدة، بالإضافة إلى استشارة طبية هاتفية بعد النتيجة، والتحقق المباشر من التغطية التأمينية عبر واتساب.
Overview
The Chronic Myeloid Leukemia NGS Panel is a comprehensive next‑generation sequencing test that screens for BCR‑ABL1 kinase domain mutations and additional gene alterations driving CML progression, informing precise tyrosine kinase inhibitor selection. In the UAE, this ISO‑certified molecular profiling enables hematologists and oncologists to tailor therapy with DHA‑mandated accuracy.
لوحة التسلسل الجيني لسرطان الدم النخاعي المزمن هي فحص شامل يكشف طفرات جين BCR‑ABL1 وتغيرات جينية أخرى، مما يُوجّه اختيار مثبطات التيروزين كيناز بدقة، وفقًا لإرشادات هيئة الصحة بدبي.
| Feature | Our CML NGS Panel | Standard BCR‑ABL qPCR Test |
|---|---|---|
| Precision | Detects 30+ gene mutations including ABL1, ASXL1, RUNX1; identifies emerging resistance variants | Quantifies only BCR‑ABL1 transcript levels; misses non‑ABL1 resistance mechanisms |
| Methodology | NGS (Illumina® platform) with bioinformatics validated per DHA/MOHAP 2026 standards | Real‑time quantitative PCR (RQ‑PCR) |
| Speed | Samples accepted 1st/16th of month; report delivered 15th/30th same month (15‑day max) | Typically 3–5 working days |
Physician Insight & Safety Protocol
“As a clinical hematologist, I emphasize that NGS results require careful correlation with peripheral blood counts, bone marrow morphology, and prior treatment history. This panel unmasks occult mutations that drive resistance, but therapeutic decisions must be made jointly with the oncologist. Never adjust TKI dosage without formal review — abrupt changes can precipitate blast crisis.” — Dr. PRABHAKAR REDDY, Consultant Hematologist (DHA License: 61713011)
⚠️ Medication Alert: Do Not Discontinue Prescribed Medication Without Consulting Your Doctor.
Stopping tyrosine kinase inhibitors or other chemotherapy agents abruptly can cause accelerated phase transformation. Always discuss any concerns with your hematologist before altering your regimen.
Exclusion Criteria & Emergency Signs
- Exclusion Criteria: Platelet count < 50,000/µL, INR > 1.5, active infection at collection site, uncontrolled bleeding diathesis, pregnancy (for bone marrow aspirate), and inability to provide mandatory NGS Test Requisition Form.
- ER Red Flags: Fever > 38.5°C, sudden severe bone pain, mental status changes, uncontrolled bleeding from puncture site, or signs of anaphylaxis — seek immediate emergency care.
Patient FAQ & Clinical Guidance
Q: What exactly does the CML NGS panel detect and why is it important?
The CML NGS panel identifies BCR‑ABL1 kinase domain mutations and other genetic alterations that drive resistance to tyrosine kinase inhibitors, enabling personalized therapy adjustments.
تكتشف لوحة التسلسل الجيني طفرات مجال الكيناز BCR‑ABL1 وتغيرات جينية أخرى تسبب مقاومة مثبطات التيروزين كيناز، مما يُتيح تعديل علاجي مُخصص.
Q: How is the sample collected and what preparation is required?
A trained phlebotomist draws 3 mL whole blood or performs a bone marrow aspirate in an EDTA tube; you must fast for 8 hours and complete the NGS Requisition Form beforehand.
يسحب فني مختص 3 مل من الدم الكامل أو نخاع العظم في أنبوب EDTA، مع صيام 8 ساعات وتعبئة نموذج الطلب الإلزامي.
Q: Will my health insurance in the UAE cover this?
Most UAE insurers reimburse the CML NGS panel when supported by a hematologist’s referral; we verify your coverage directly via WhatsApp at +971 54 548 8731 before scheduling.
تُغطي معظم شركات التأمين في الإمارات هذا الفحص عند وجود تحويل من طبيب أمراض دم؛ نتحقق من التغطية عبر واتساب قبل الحجز.
2026 UAE Healthcare Compliance
This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Article 87) for medical testing integrity, CDS Law 2026 – mandates for minors, and the UAE Personal Data Protection Law (PDPL). Our facility operates under DHA license 9834453, ISO 9001:2015 certification (INT/EGQ/2509DA/3139), and employs only DHA‑licensed healthcare professionals.
ICD‑10‑CM (2026): C92.10 (CML not in remission), C92.11 (CML in remission), C92.12 (CML in relapse). LOINC: 92928‑0 (Chronic myeloid leukemia multigene panel – Blood or Bone marrow by Sequencing) – loinc.org/92928-0.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians